Tentarix Biotherapeutics

Introducing Dr. Andrew D. Kidd, the new Chief Executive Officer of Tentarix Biotherapeutics. With a rich history of leadership in biotechnology, Andy is poised to propel Tentarix forward to transform the landscape of precision oncology and immunology! Click here for more: https://lnkd.in/gBxaeetC

🐙 Go Team Tentarix! 🐙 Tentarix Biotherapeutics is stepping into the arena of the Fierce Biotech Best Name in Biotech Tournament, proudly seeded #1 in the Folklore / Animals division! Our innovative name, mirroring the precision and intelligence of our molecular designs, makes us a strong contender to go all the way. Support Tentarix by casting your vote today: https://lnkd.in/gK-SkPa2 #TentarixBiotherapeutics #BiotechBracket

🐙 Go Team Tentarix! 🐙 Tentarix Biotherapeutics is stepping into the arena of the Fierce Biotech Best Name in Biotech Tournament, proudly seeded #1 in the Folklore / Animals division! Our innovative name, mirroring the precision and intelligence of our molecular designs, makes us a strong contender to go all the way. Support Tentarix by casting your vote today: https://lnkd.in/gK-SkPa2 #TentarixBiotherapeutics #BiotechBracket

Tentarix is #Hiring! We are looking to expand our growing San Diego team! Dive in for more information: https://lnkd.in/gF57EJP8

Exciting news: Tentarix and AbbVie are joining forces to potentially revolutionize oncology and immunology treatment through conditionally-active multi-specific biologics. Read more about our groundbreaking collaboration: https://lnkd.in/gn2_DhiW

Exciting news: Tentarix and AbbVie are joining forces to potentially revolutionize oncology and immunology treatment through conditionally-active multi-specific biologics. Read more about our groundbreaking collaboration: https://lnkd.in/gn2_DhiW

We are #Hiring! Several incredible opportunities are available on our growing team. Currently accepting applications from creative, hands-on, self-directed, excellent communicators to join our team. We offer autonomy, flexibility, a modern culture, and the best tools to ensure individual and collective success. Explore all job openings and apply here: https://lnkd.in/gF57EJP8

The excitement around our Tentacles™ platform continues to grow! Today we announced the completion of our Series B financing, bringing total equity and upfront deal consideration to $132 Million. Catch up on our Series B details here: https://lnkd.in/gM34hP4k

We're #hiring creative, hands-on, self-directed, excellent communicators to join our team. We offer autonomy, flexibility, a modern culture, and the best tools to ensure individual and collective success. We've launched some exciting news this week too! Check out our new collaboration: https://lnkd.in/gzXY9dSM Apply here: https://lnkd.in/g2eYMRN7